Revlimid is a medicine containing the active ingredient(s) lenalidomide. On this page you will find out more about Revlimid, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: lenalidomide
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Revlimid 15 mg hard capsule, 21
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Multiple Myeloma (MM) Revlimid is indicated for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. Revlimid is indicated for the maintenance treatment of patients with newly diagnosed mulitple myeloma who have undergone autologous stem cell transplantation. Revlimid in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.,Myelodysplastic Syndromes (MDS) Revlimid is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL) Revlimid is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
Table of characteristics
|Visual appearance||white to off-white opaque body/ powder blue opaque cap size 0 capsules marked "15mg REV" in black|
|Dosage Form||Capsule, hard|
|Route of administration||Oral|
21 capsules: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||Store in Original Container|
|Life time||3 Years|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 May 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
Revlimid Capsules - myDr.com.au
Revlimid Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Diagnosis & Treatment for Kaposi Sarcoma - Cancer Council Victoria
Radiotherapy can be used to help get rid of the lesions. It works by killing the cancer cells with high-energy rays. Chemotherapy can also be used if there are Kaposi sarcoma lesions inside the body and you're having symptoms such as fever and weight loss.
Read more on Cancer Council Victoria website
Found 1 results
Oral targeted therapy for cancer | Issue 5 | Volume 38 | Australian Prescriber
Oral targeted therapies are increasingly being used to treat cancer. They work by interfering with specific molecules or pathways involved in tumour...
Read more on Australian Prescriber website